DE3068924D1 - Heparin fragments having a selective anticoagulation activity and process for their preparation - Google Patents
Heparin fragments having a selective anticoagulation activity and process for their preparationInfo
- Publication number
- DE3068924D1 DE3068924D1 DE8080850002T DE3068924T DE3068924D1 DE 3068924 D1 DE3068924 D1 DE 3068924D1 DE 8080850002 T DE8080850002 T DE 8080850002T DE 3068924 T DE3068924 T DE 3068924T DE 3068924 D1 DE3068924 D1 DE 3068924D1
- Authority
- DE
- Germany
- Prior art keywords
- heparin fragments
- preparation
- anticoagulation activity
- selective
- sulphate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
- C08B37/0078—Degradation products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE7900164 | 1979-01-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3068924D1 true DE3068924D1 (en) | 1984-09-20 |
Family
ID=20336970
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8080850002T Expired DE3068924D1 (en) | 1979-01-08 | 1980-01-07 | Heparin fragments having a selective anticoagulation activity and process for their preparation |
Country Status (11)
Country | Link |
---|---|
US (1) | US4303651A (de) |
EP (1) | EP0014184B2 (de) |
JP (1) | JPS6344764B2 (de) |
AT (1) | ATE8998T1 (de) |
CA (1) | CA1136620A (de) |
DE (1) | DE3068924D1 (de) |
DK (1) | DK160764C (de) |
NL (1) | NL930104I2 (de) |
NO (1) | NO150801C (de) |
SU (1) | SU1209033A3 (de) |
WO (1) | WO1980001383A1 (de) |
Families Citing this family (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE449753B (sv) * | 1978-11-06 | 1987-05-18 | Choay Sa | Mukopolysackaridkomposition med reglerande verkan pa koagulation, lekemedel innehallande densamma samt forfarande for framstellning derav |
FR2440376A1 (fr) * | 1978-11-06 | 1980-05-30 | Choay Sa | Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir |
US4500519A (en) * | 1978-11-06 | 1985-02-19 | Choay S.A. | Mucopolysaccharides having biological properties, preparation and method of use |
US4692435A (en) * | 1978-11-06 | 1987-09-08 | Choay, S.A. | Mucopolysaccharide composition having a regulatory action on coagulation, medicament containing same and process of preparation |
FR2478646A2 (fr) * | 1980-03-20 | 1981-09-25 | Choay Sa | Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir |
FR2482611B1 (fr) * | 1980-05-14 | 1986-03-07 | Pharmindustrie | Nouveaux polysaccharides sulfates, procedes pour leur preparation et leur utilisation comme medicaments |
US4438261A (en) | 1980-05-19 | 1984-03-20 | Riker Laboratories, Inc. | Anticoagulant substance |
CA1171375A (en) * | 1980-09-15 | 1984-07-24 | Ulf P.F. Lindahl | Oligosaccharides having selective anticoagulation activity |
JPH0258920B2 (de) * | 1980-10-09 | 1990-12-11 | Boehringer Mannheim Gmbh | |
FR2503714B1 (fr) * | 1981-04-10 | 1986-11-21 | Choay Sa | Procede d'obtention de mucopolysaccharides biologiquement actifs, de purete elevee, par depolymerisation de l'heparine |
FR2535324A1 (fr) * | 1982-10-27 | 1984-05-04 | Choay Sa | Station perfectionnee pour l'epuration d'eaux usees |
FR2504535B1 (fr) * | 1981-04-28 | 1987-08-14 | Choay Sa | Disaccharides derives d'un acide uronique et d'une glucosamine et compositions pharmaceutiques les contenant pour le controle de la coagulation sanguine |
US4818816A (en) * | 1981-04-28 | 1989-04-04 | Choay, S.A. | Process for the organic synthesis of oligosaccharides and derivatives thereof |
ATE15142T1 (de) | 1981-05-21 | 1985-09-15 | Akzo Nv | Antithrombotikum auf basis von polysacchariden, verfahren zur dessen herstellung und medizinale zusammensetzungen. |
US4396762A (en) * | 1981-08-24 | 1983-08-02 | Massachusetts Institute Of Technology | Heparinase derived anticoagulants |
AU563351C (en) * | 1982-01-15 | 2003-06-19 | Glaxo Group Limited | Synthesis of oligosaccharides |
CA1265132A (en) * | 1982-01-15 | 1990-01-30 | Mahmoud Nassr | Process for the organic synthesis of oligosaccharides and derivatives thereof |
US4539398A (en) * | 1982-01-22 | 1985-09-03 | Riker Laboratories, Inc. | Affinity fractionation of heparin on immobilized Concanavalin A |
ZA829463B (en) * | 1982-07-19 | 1983-10-26 | Hepar Ind Inc | Process for manufacturing low molecular weight heparins by depolymerization of normal heparin |
FR2538404B1 (de) * | 1982-12-28 | 1985-08-23 | Anic Spa | |
IT1195497B (it) * | 1983-03-08 | 1988-10-19 | Opocrin Spa | Procedimento per la preparazione di frazioni oligosaccaridiche dotate di proprieta' farmacologiche per degradazione chimica di eparina |
FR2548672A1 (fr) * | 1983-07-04 | 1985-01-11 | Pharmuka Lab | Oligosaccharides sulfates et leur utilisation comme medicaments |
GB8614189D0 (en) * | 1986-06-11 | 1986-07-16 | Leo Pharm Prod Ltd | Pharmaceutical composition |
US4942156A (en) * | 1986-08-20 | 1990-07-17 | Hepar Industries, Inc. | Low molecular weight heparin derivatives having improved anti-Xa specificity |
US4745106A (en) * | 1986-08-20 | 1988-05-17 | Griffin Charles C | Heparin derivatives having improved anti-Xa specificity |
IT1213384B (it) * | 1986-11-24 | 1989-12-20 | Lab Derivati Organici Mediolan | Processo per la preparazione controllata di gilcosaminoglicani a basso peso molecolare. |
FR2614026B1 (fr) * | 1987-04-16 | 1992-04-17 | Sanofi Sa | Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques |
EP0337327A1 (de) * | 1988-04-09 | 1989-10-18 | Bioiberica, S.A. | Verfahren zur Herstellung von neuen Oligosaccharid-Fragmenten durch kontrollierte chemische Depolymerisation von Heparin |
IT1230582B (it) | 1988-10-21 | 1991-10-28 | Opocrin S P A Lab Farmabiologi | Oliogosaccaridi di dermatan solfato ed eparina aventi attivita' antiaterosclerotica |
AU7742591A (en) * | 1990-04-06 | 1991-10-30 | Washington University | Anticoagulant oligosaccharides |
USRE38743E1 (en) | 1990-06-26 | 2005-06-14 | Aventis Pharma S.A. | Mixtures of particular LMW heparinic polysaccharides for the prophylaxis/treatment of acute thrombotic events |
US5665379A (en) * | 1990-09-28 | 1997-09-09 | Pharmacia & Upjohn Aktiebolag | Lipid particle forming matrix, preparation and use thereof |
FI921689A (fi) * | 1991-04-16 | 1992-10-17 | Seikagagu Kogyo Kabushiki Kais | Oligosackarid med affinitet foer fibroblasttillvaextfaktor och foerfarande foer framstaellning av denna |
SE9101155D0 (sv) * | 1991-04-18 | 1991-04-18 | Kabi Pharmacia Ab | Novel heparin derivatives |
GB9206291D0 (en) * | 1992-03-23 | 1992-05-06 | Cancer Res Campaign Tech | Oligosaccharides having growth factor binding affinity |
DE4217916C2 (de) * | 1992-05-30 | 1995-05-18 | Job Prof Dr Med Harenberg | N-Alkylamin- und N-Arylalkylaminderivate von Heparin, Verfahren zu ihrer Herstellung und ihrer Verwendung |
GB9306255D0 (en) * | 1993-03-25 | 1993-05-19 | Cancer Res Campaign Tech | Heparan sulphate oligosaccharides having hepatocyte growth factor binding affinity |
SE9302135D0 (sv) * | 1993-06-18 | 1993-06-18 | Kabi Pharmacia Ab | New pharmaceutical composition |
DE69623840D1 (de) * | 1995-03-31 | 2002-10-31 | Hamilton Civic Hospitals Res | Zusammensetzung zur Hemmung der Thromboseentstehung |
SK286024B6 (sk) * | 1996-11-27 | 2008-01-07 | Aventis Pharmaceuticals Inc. | Farmaceutický prostriedok a použitie tohto prostriedku na prípravu liečiva |
WO1998055515A1 (en) * | 1997-06-06 | 1998-12-10 | Hamilton Civic Hospitals Research Development, Inc. | Modified low molecular weight heparin that inhibits clot associated coagulation factors |
WO2000065521A2 (en) | 1999-04-23 | 2000-11-02 | Massachusetts Institute Of Technology | System and method for polymer notation |
BR0012202A (pt) * | 1999-06-30 | 2002-04-02 | Hamilton Civic Hospitals Res | Composições de heparina de peso molecular médio (mmwh), método de tratamento de uma condição trombótica, método de prevenção da formação de um trombo, método de inibição da formação de trombos, composição farmacêutica, método de tratamento de trombose venosa profunda, método de prevenção de embolia pulmonar, método de preparação e usos de uma composição de mmwh |
JP2002097143A (ja) * | 2000-07-18 | 2002-04-02 | Koyo Chemical Kk | 血流改善剤及び血栓予防治療剤または食品 |
AU2001291549A1 (en) * | 2000-09-08 | 2002-03-22 | Hamilton Civic Hospitals Research Development Inc. | Antithrombotic compositions |
JP2006096668A (ja) * | 2002-11-08 | 2006-04-13 | Ono Pharmaceut Co Ltd | エラスターゼ阻害剤と血液凝固系および/または線溶系酵素阻害剤との組み合わせからなる医薬 |
US6933372B2 (en) | 2003-03-07 | 2005-08-23 | Warner-Lambert Company | Method to produce a solid form of heparin |
BRPI0410844A (pt) * | 2003-06-05 | 2006-06-27 | Centelion | fator de crescimento de fibroblasto de codificação de plasmìdeo para o tratamento de defeitos angiogênicos associados com hipercolesterolemia ou diabetes |
ITMI20031679A1 (it) * | 2003-08-29 | 2005-02-28 | Opocrin Spa | Processo per la produzione di eparine a basso peso |
US20050096294A1 (en) * | 2003-10-31 | 2005-05-05 | Takashi Komai | Novel anti-coagulant |
EP1582531A1 (de) | 2004-03-24 | 2005-10-05 | Aventis Pharma S.A. | Verfahren zur Oxydierung nicht-fraktionierten Heparins und die Detektion der Anwesenheit oder Abwesenheit von Glykoserin in Heparin und in von Heparin abgeleiteten Produkten |
ATE552004T1 (de) | 2005-11-30 | 2012-04-15 | Istituto G Ronzoni | Oral verabreichbare heparinderivate |
US8569262B2 (en) | 2007-11-02 | 2013-10-29 | Momenta Pharmaceuticals, Inc. | Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization |
EP2205642B1 (de) * | 2007-11-02 | 2016-01-27 | Momenta Pharmaceuticals, Inc. | Nicht gerinnungshemmende polysaccharidzusammensetzungen |
US8592393B2 (en) * | 2007-11-02 | 2013-11-26 | Momenta Pharmaceuticals, Inc. | Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization |
CA2724840A1 (en) * | 2008-05-20 | 2009-11-26 | Crystal Clear Partnership | Separation of polysaccharides by charge density gradient |
ES2340902B1 (es) * | 2008-07-01 | 2011-05-03 | Laboratorios Farmaceuticos Rovi, S.A. | Composicion farmaceutica con glicosaminoglicanos y su uso en tratamiento de ulceras cronicas. |
JP5982361B2 (ja) | 2010-04-16 | 2016-08-31 | モメンタ ファーマシューティカルズ インコーポレイテッド | 組織標的化方法 |
US10017585B2 (en) | 2010-06-17 | 2018-07-10 | Momenta Pharmaceuticals, Inc. | Methods and compositions for promoting hair growth |
ES2656613T3 (es) * | 2011-12-19 | 2018-02-27 | Dilafor Ab | Glicosaminoglicanos no anticoagulantes que comprenden unidades de repetición de disacáridos y su uso médico |
WO2013095215A1 (en) | 2011-12-19 | 2013-06-27 | Dilaforette Ab | Low anticoagulant heparins |
EP3003324A4 (de) | 2013-05-28 | 2017-01-25 | Momenta Pharmaceuticals, Inc. | Pharmazeutische zusammensetzungen |
RU2612813C1 (ru) * | 2015-12-07 | 2017-03-13 | Павел Андреевич Канаев | Способ получения гепарина |
WO2019159092A1 (en) | 2018-02-14 | 2019-08-22 | Biological E Limited | Improved process for the preparation of dalteparin sodium |
WO2022015794A1 (en) | 2020-07-14 | 2022-01-20 | Optimvia, Llc | Methods for synthesizing non-anticoagulant heparan sulfate |
AU2020310172A1 (en) | 2019-07-09 | 2022-03-03 | Optimvia Llc | Methods for synthesizing anticoagulant polysaccharides |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3135660A (en) * | 1956-11-09 | 1964-06-02 | Riker Laboratories Inc | Method for purifying sulfated carbohydrates with oxidizing agents |
US3066076A (en) * | 1958-12-15 | 1962-11-27 | Fo We Forschungs Und Verwertun | Soluble heparin product and process for preparing same |
FR2100735B1 (de) * | 1970-06-08 | 1974-08-30 | Mar Pha Etu Expl Marques | |
DE2148011C3 (de) * | 1970-10-05 | 1978-11-09 | Aminkemi Ab | Verfahren zum Herstellen nichtthrombogener Kunststoffoberflächen |
US3766167A (en) * | 1971-03-26 | 1973-10-16 | Research Corp | Orally active anticoagulant |
GB1399824A (en) * | 1971-08-16 | 1975-07-02 | Mar Pha Etu Expl Marques | Heparin esters |
IT1083903B (it) * | 1977-08-09 | 1985-05-25 | Lobo Srl | Oligo-eteropolisaccaridi con attivita' eparinosimili,procedimento per il loro ottenimento e relative composizioni terapeutiche |
-
1980
- 1980-01-03 CA CA000343014A patent/CA1136620A/en not_active Expired
- 1980-01-04 US US06/109,936 patent/US4303651A/en not_active Expired - Lifetime
- 1980-01-07 EP EP80850002A patent/EP0014184B2/de not_active Expired
- 1980-01-07 AT AT80850002T patent/ATE8998T1/de active
- 1980-01-07 JP JP55500234A patent/JPS6344764B2/ja not_active Expired
- 1980-01-07 DE DE8080850002T patent/DE3068924D1/de not_active Expired
- 1980-01-07 WO PCT/SE1980/000005 patent/WO1980001383A1/en unknown
- 1980-09-05 NO NO802626A patent/NO150801C/no unknown
- 1980-09-05 DK DK380280A patent/DK160764C/da not_active IP Right Cessation
-
1981
- 1981-02-06 SU SU813244902A patent/SU1209033A3/ru active
-
1993
- 1993-01-28 NL NL930104C patent/NL930104I2/nl unknown
Also Published As
Publication number | Publication date |
---|---|
DK380280A (da) | 1980-09-05 |
CA1136620A (en) | 1982-11-30 |
US4303651A (en) | 1981-12-01 |
WO1980001383A1 (en) | 1980-07-10 |
EP0014184A3 (en) | 1980-10-01 |
DK160764C (da) | 1991-09-23 |
SU1209033A3 (ru) | 1986-01-30 |
EP0014184B2 (de) | 1989-10-18 |
JPS56500066A (de) | 1981-01-22 |
NO150801C (no) | 1984-12-27 |
DK160764B (da) | 1991-04-15 |
NL930104I1 (nl) | 1993-10-01 |
ATE8998T1 (de) | 1984-09-15 |
EP0014184A2 (de) | 1980-08-06 |
NO802626L (no) | 1980-09-05 |
JPS6344764B2 (de) | 1988-09-06 |
NL930104I2 (nl) | 1997-02-03 |
NO150801B (no) | 1984-09-10 |
EP0014184B1 (de) | 1984-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3068924D1 (en) | Heparin fragments having a selective anticoagulation activity and process for their preparation | |
DE2861170D1 (en) | Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof, and process for their manufacture | |
IL70311A (en) | 4-aminoalkyl-2(3h)-indolones,process for their preparation and pharmaceutical compositions containing them | |
DE2862100D1 (en) | Acylanilides, process for their manufacture and pharmaceutical and veterinary compositions containing them | |
EG14227A (en) | N-phenoxyalkyl imidazoles as selective infibitors of the thermoboxane synthetase enzyme,pharmaceutical compositions thereof and process for their preparation | |
ES482241A1 (es) | Procedimiento de obtencion de un semiester de un esteril glicosido farmaceuticamente aceptable. | |
IL55109A (en) | 1-acyl-2-cyanoaziridines,process for their preparation and pharmaceutical compositions containing them | |
EP0245813A3 (en) | Edta-free heparins, heparin fractions and fragments, processes for their preparation and pharmaceutical compositions containing them | |
DE2861482D1 (en) | Pyrazino-benzoxazepine and -benzthiazepine derivatives, processes for their production and pharmaceutical compositions containing them | |
IE821049L (en) | Aminocyclitol derivatives | |
ZA792853B (en) | New antibiotics,processes for their production and pharmaceutical compositions containing them | |
ES8302460A1 (es) | Procedimiento para preparar un complejo de antitrombina y de heparina de alta actividad. | |
ZA818609B (en) | Pyrimidones,process for their preparation and pharmaceutical compositions containing them | |
ES486706A1 (es) | Un procedimiento de purificacion de acido dihidroxi-3 ,7 ,- (5 )colanico | |
IL61437A0 (en) | Macrolide antibiotics, process for their production and pharmaceutical compositions containing them | |
IL54718A (en) | 17beta-hydroxy delta4-androsten-3-ones,process for their manufacture and pharmaceutical compositions containing them | |
IL59934A (en) | 4-diazo steroids,process for their preparation and pharmaceutical compositions containing them | |
ZA782432B (en) | 2-benzyl-perhydroazepines,process for their preparation and pharmaceutical compositions containing them | |
IL55139A (en) | Substituted 2-cyclopropyl-chromones,process for their preparation and pharmaceutical compositions containing them | |
DE2860709D1 (en) | 1-substituted aminoindolines, process for their production and pharmaceutical compositions containing them | |
IL52207A (en) | Substituted 2-vinyl-chromones, process for their preparation and pharmaceutical compositions containing them | |
ZA804031B (en) | 4-phenyl-4,5,6,7-tetrahydro-pyrrolo (2,3-c) pyridines process for their preparation and pharmaceutical compositions thereof | |
DE2965524D1 (en) | Rutin poly(h-) sulfates, method for their preparation and pharmaceutical compositions containing them | |
DE3160050D1 (en) | 3-desoxy-delta-15 steroids, process for their preparation and pharmaceutical compositions containing them | |
DE2961309D1 (en) | Sulfonyl ureas, processes for their preparation and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8366 | Restricted maintained after opposition proceedings | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: PHARMACIA AB, STOCKHOLM, SE |
|
8328 | Change in the person/name/address of the agent |
Free format text: TER MEER-MUELLER-STEINMEISTER & PARTNER, PATENTANWAELTE, 81679 MUENCHEN |
|
8328 | Change in the person/name/address of the agent |
Free format text: DERZEIT KEIN VERTRETER BESTELLT |
|
8327 | Change in the person/name/address of the patent owner |
Owner name: PHARMACIA & UPJOHN AB, STOCKHOLM, SE |